EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proton Pump Inhibitor Use and Incident Epilepsy in the UK Biobank: Evidence From Pharmacovigilance and Multi‐Omics Analyses

Minghao Li, Yiqian Li, Yuxi Zhang iD, Balkissou Seebo Saibou, Yifei Chen, Jiayi Xing, Chao Jin, Yuchen Xu, Jiahe Lin, Xinshi Wang iD

CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)

DOI: 10.1002/cns.71223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 04.11.2026. Verfasst von Minghao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Epilepsy, Pharmacovigilance, Biological Specimen Banks. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Proton pump inhibitors (PPIs) are widely used, but their association with incident epilepsy remains uncertain. We examined this association in the UK Biobank and integrated evidence from pharmacovigilance and multi‐omics.

Methods

We included 492,858 UK Biobank participants without epilepsy at baseline. Cox models, age‐ and sex‐stratified analyses, active‐comparator analyses against H2RA users, propensity score matching, competing‐risk models, and sensitivity analyses were performed. FAERS disproportionality, Olink proteomics, and NMR metabolomics provided supportive evidence.

Results

Baseline PPI use was associated with incident epilepsy after full adjustment (HR 1.43, 95% CI 1.29–1.59) and in the PPI‐H2RA propensity score‐matched analysis (HR 1.41, 95% CI 1.03–1.94). In the GP‐linked subset, requiring an ASM prescription within 365 days after diagnosis yielded HR 1.47 (95% CI 1.07–2.02). FAERS showed a PPI‐epilepsy reporting signal (ROR 1.70, 95% CI 1.61–1.79). Proteomic and metabolomic analyses identified immune‐inflammatory and metabolic associations.

Conclusion

Baseline PPI use was associated with incident epilepsy in the UK Biobank. Active‐comparator, outcome‐definition, and prescription‐supported analyses supported the primary association. Pharmacovigilance and molecular findings provided complementary evidence but did not establish causality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsEpilepsyPharmacovigilanceBiological Specimen BanksHumansFemaleUnited KingdomMaleMultiomicsMiddle AgedAgedProteomicsMetabolomicsAdultUK Biobank

Stichwörter der Autor:innen

FAERSUK biobankepilepsyinflammationmetabolomicspharmacovigilanceproteomicsproton pump inhibitors

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
  • Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
  • Key Laboratory of Novel Nuclide Technologies on Precision Diagnosis and Treatment & Clinical Transformation of Wenzhou City, Wenzhou, Zhejiang Province, People's Republic of China.

ORCID-Profile: Yuxi Zhang, Xinshi Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, M., Li, Y., Zhang, Y., Saibou, B. S., Chen, Y., Xing, J., Jin, C., Xu, Y., Lin, J., & Wang, X. (2026). Proton Pump Inhibitor Use and Incident Epilepsy in the UK Biobank: Evidence From Pharmacovigilance and Multi‐Omics Analyses. CNS Neuroscience & Therapeutics, 32(11). https://doi.org/10.1002/cns.71223

Vancouver

Li M, Li Y, Zhang Y, Saibou BS, Chen Y, Xing J, et al. Proton Pump Inhibitor Use and Incident Epilepsy in the UK Biobank: Evidence From Pharmacovigilance and Multi‐Omics Analyses. CNS Neuroscience & Therapeutics. 2026;32(11). doi:10.1002/cns.71223

BibTeX
@article{Li2026,
  author = {Li, Minghao and Li, Yiqian and Zhang, Yuxi and Saibou, Balkissou Seebo and Chen, Yifei and Xing, Jiayi and Jin, Chao and Xu, Yuchen and Lin, Jiahe and Wang, Xinshi},
  title = {Proton Pump Inhibitor Use and Incident Epilepsy in the UK Biobank: Evidence From Pharmacovigilance and Multi‐Omics Analyses},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {11},
  doi = {10.1002/cns.71223}
}
Kostenlos starten →